- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/505 - Erythropoietin [EPO]
Patent holdings for IPC class C07K 14/505
Total number of patents in this class: 531
10-year publication summary
|
45
|
46
|
43
|
33
|
36
|
48
|
33
|
26
|
17
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Modernatx, Inc. | 1279 |
57 |
| Translate bio, Inc. | 416 |
32 |
| Opko Biologics Ltd. | 80 |
23 |
| The Trustees of the University of Pennsylvania | 4441 |
20 |
| Hoffmann-La Roche Inc. | 3849 |
16 |
| JCR Pharmaceuticals Co., Ltd. | 226 |
10 |
| Curevac SE | 297 |
10 |
| Amgen Inc. | 4486 |
8 |
| Rutgers, The State University of New Jersey | 1992 |
8 |
| Ubiprotein, Corp. | 12 |
8 |
| F. Hoffmann-La Roche AG | 7792 |
7 |
| Acceleron Pharma Inc. | 339 |
7 |
| Arcturus Therapeutics, Inc. | 185 |
6 |
| Institute for Research in Biomedicine (IRB) | 42 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4822 |
6 |
| Yale University | 2573 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6722 |
5 |
| Life Technologies Corporation | 3460 |
5 |
| Danmarks Tekniske Universitet | 1043 |
5 |
| The Scripps Research Institute | 1347 |
5 |
| Other owners | 281 |